DNA-cloaked nanoparticles for tumor microenvironment-responsive activation.

[1]  G. Shim,et al.  Lipid-based nanoparticles for photosensitive drug delivery systems , 2022, Journal of Pharmaceutical Investigation.

[2]  Y. Oh,et al.  DNA-based artificial dendritic cells for in situ cytotoxic T cell stimulation and immunotherapy , 2021, Bioactive materials.

[3]  Y. Oh,et al.  Genome-Editing-Mediated Restructuring of Tumor Immune Microenvironment for Prevention of Metastasis. , 2021, ACS nano.

[4]  L. Zender,et al.  The immunological and metabolic landscape in primary and metastatic liver cancer , 2021, Nature Reviews Cancer.

[5]  H. Kuh,et al.  Tumor spheroid-based microtumor models for preclinical evaluation of anticancer nanomedicines , 2021, Journal of Pharmaceutical Investigation.

[6]  T. Ishida,et al.  Anti-PEG IgM production and accelerated blood clearance phenomenon after the administration of PEGylated exosomes in mice. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[7]  F. Plou,et al.  The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies , 2021, International journal of molecular sciences.

[8]  G. Nagaraju,et al.  Reactive oxygen species (ROS): critical roles in breast tumor microenvironment. , 2021, Critical reviews in oncology/hematology.

[9]  Zhuxian Zhou,et al.  Active Transportation of Liposome Enhances Tumor Accumulation, Penetration, and Therapeutic Efficacy. , 2020, Small.

[10]  Xiaoyuan Chen,et al.  Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death , 2020, Nature Communications.

[11]  Xunbo Jin,et al.  Roles of Reactive Oxygen Species in Biological Behaviors of Prostate Cancer , 2020, BioMed research international.

[12]  Young Bong Kim,et al.  Tannic acid-functionalized boron nitride nanosheets for theranostics. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Yun‐Sil Lee,et al.  Lung-targeted delivery of TGF-β antisense oligonucleotides to treat pulmonary fibrosis. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[14]  Xiaolong Liu,et al.  Tumor microenvironment-activated self-recognizing nanodrug through directly tailored assembly of small-molecules for targeted synergistic chemotherapy. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[15]  Guoqiang Chen,et al.  Biomimetic, Hypoxia‐Responsive Nanoparticles Overcome Residual Chemoresistant Leukemic Cells with Co‐Targeting of Therapy‐Induced Bone Marrow Niches , 2020, Advanced Functional Materials.

[16]  Mi-Gyeong Kim,et al.  Noncovalent tethering of nucleic acid aptamer on DNA nanostructure for targeted photo/chemo/gene therapies. , 2020, Nanomedicine : nanotechnology, biology, and medicine.

[17]  Wei-Guo Zhu,et al.  Tumor pH-responsive metastable-phase manganese sulfide nanotheranostics for traceable hydrogen sulfide gas therapy primed chemodynamic therapy , 2020, Theranostics.

[18]  Dong Yun Lee,et al.  PEGylated Bilirubin-coated Iron Oxide Nanoparticles as a Biosensor for Magnetic Relaxation Switching-based ROS Detection in Whole Blood , 2020, Theranostics.

[19]  S. Bohlander.  A new kid on the block for acute myeloid leukemia treatment? Homoharringtonine interferes with key pathways in acute myeloid leukemia cells , 2020, Haematologica.

[20]  Thomas P. Davis,et al.  A pH-responsive nanoparticle targets the neurokinin 1 receptor in endosomes to prevent chronic pain , 2019, Nature Nanotechnology.

[21]  M. Ruscica,et al.  Lactate Buildup at the Site of Chronic Inflammation Promotes Disease by Inducing CD4+ T Cell Metabolic Rewiring , 2019, Cell metabolism.

[22]  Chen Jiang,et al.  Dandelion‐Like Tailorable Nanoparticles for Tumor Microenvironment Modulation , 2019, Advanced science.

[23]  M. Belov,et al.  Transmission-mode MALDI-2 mass spectrometry imaging of cells and tissues at subcellular resolution , 2019, Nature Methods.

[24]  J. Wagner,et al.  A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential , 2019, BMC Cancer.

[25]  Jianjun Chen,et al.  Homoharringtonine exhibits potent anti-tumor effect and modulates DNA epigenome in acute myeloid leukemia by targeting SP1/TET1/5hmC , 2019, Haematologica.

[26]  Young Bong Kim,et al.  Sequential activation of anticancer therapy triggered by tumor microenvironment‐selective imaging , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[27]  A. Kros,et al.  DePEGylation strategies to increase cancer nanomedicine efficacy. , 2019, Nanoscale horizons.

[28]  Y. Oh,et al.  Staphylococcus aureus-mimetic control of antibody orientation on nanoparticles. , 2019, Nanomedicine : nanotechnology, biology, and medicine.

[29]  Martin R. Gill,et al.  Transition metal compounds as cancer radiosensitizers. , 2019, Chemical Society reviews.

[30]  Junmin Li,et al.  Homoharringtonine deregulates MYC transcriptional expression by directly binding NF-κB repressing factor , 2019, Proceedings of the National Academy of Sciences.

[31]  Bing Yu,et al.  Application and design of esterase-responsive nanoparticles for cancer therapy , 2019, Drug delivery.

[32]  S. Hashemy,et al.  Oxidative stress in cervical cancer pathogenesis and resistance to therapy , 2018, Journal of cellular biochemistry.

[33]  A. Bernkop‐Schnürch.  Strategies to overcome the polycation dilemma in drug delivery , 2018, Advanced drug delivery reviews.

[34]  Suming Chen,et al.  Mass spectrometry imaging of the in situ drug release from nanocarriers , 2018, Science Advances.

[35]  Gregg A. Duncan,et al.  PEGylated enhanced cell penetrating peptide nanoparticles for lung gene therapy , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[36]  J. Werner,et al.  Reactive oxygen species and colorectal cancer , 2018, Journal of cellular physiology.

[37]  Y. Oh,et al.  Chemokine-mimetic plerixafor derivative for tumor-specific delivery of nanomaterials , 2018, Nano Research.

[38]  D. DeAngelo,et al.  A Review of Omacetaxine: A Chronic Myeloid Leukemia Treatment Resurrected , 2018, Oncology and Therapy.

[39]  Zhigang Wang,et al.  Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma , 2018, Theranostics.

[40]  Lilin,et al.  Synthesis, Positron Emission Tomography Imaging, and Therapy of Diabody Targeted Drug Lipid Nanoparticles in a Prostate Cancer Murine Model. , 2017 .

[41]  Shanrong Zhang,et al.  Interactions of Renal-Clearable Gold Nanoparticles with Tumor Microenvironments: Vasculature and Acidity Effects. , 2017, Angewandte Chemie.

[42]  Luisa M Russell,et al.  Tumor accumulation of liposomal doxorubicin in three murine models: Optimizing delivery efficiency. , 2017, Nanomedicine : nanotechnology, biology, and medicine.

[43]  D. Oupický,et al.  Dual-Function Polymeric HPMA Prodrugs for the Delivery of miRNA , 2017, Molecular pharmaceutics.

[44]  S. Batra,et al.  Polyplex-mediated inhibition of chemokine receptor CXCR4 and chromatin-remodeling enzyme NCOA3 impedes pancreatic cancer progression and metastasis. , 2016, Biomaterials.

[45]  J. Schellens,et al.  Metabolite profiling of 14C-omacetaxine mepesuccinate in plasma and excreta of cancer patients , 2016, Xenobiotica; the fate of foreign compounds in biological systems.

[46]  Joo Yeon Park,et al.  Polyaptamer DNA nanothread-anchored, reduced graphene oxide nanosheets for targeted delivery. , 2015, Biomaterials.

[47]  Daniel K. Bonner,et al.  Layer-by-Layer Assembled Antisense DNA Microsponge Particles for Efficient Delivery of Cancer Therapeutics , 2014, ACS nano.

[48]  Gang Zheng,et al.  Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency. , 2014, ACS nano.

[49]  Soondong Lee,et al.  Liposomal Co-Delivery of Omacetaxine Mepesuccinate and Doxorubicin for Synergistic Potentiation of Antitumor Activity , 2014, Pharmaceutical Research.